Upcoming Events
 Boston Single Cell Network Meeting
Dana-Farber Cancer Institute Dana 1620 (Smith Family Room)
Tuesday, Dec. 2
4:00-5:30 PM

The HSCI Technology Series

was developed to best serve researchers in their day-to-day experimental work. Experts in up-and-coming protocols present and answer your questions. Please join us at future events:

HSCI Technology Series: CRISPR
Sherman Fairchild 268
Thursday, Dec. 4
12:00-1:00 PM
HSCI iPS Core Training
December 4-5, 2014
Bauer Building Room B01
Human Pluripotent Stem Cell Culture: Feeder versus Feeder-free
 $425 for HSCI members. Register today.
Joseph Bonventre, MD, PhD, has been appointed to the National Diabetes & Digestive & Kidney Diseases Advisory Council.

Florida fishing tournament raises money for childhood cancer research: Funds will help support pediatric leukemia work led by David Langenau, PhD.
People News
Zhigang He, PhD, a neurologist at Boston Children's Hospital, and Brian Wainger, MD, PhD, a neurologist at Massachusetts General Hospital, join as HSCI Principal Faculty members; Andrew Lane, MD, PhD, an oncologist at the Dana-Farber Cancer Institute, joins as an Affiliated Faculty member.

Art student (the daughter of HSCRB's M. Willy Lensch, PhD) collaborates with George Daley Lab on Stem Cell Reports cover art.
HSCI-CIRM hold annual symposium
Stem Cells 2.0: Harvard/California, now in its eighth year, drives innovative research between CIRM/HSCI scientists

Forty principal investigators from Harvard and California gathered at Massachusetts General Hospital last week for a casual, annual symposium focused on discussing unpublished work, receiving critical feedback, and forming cross-country collaborations. Fernando Camargo, PhD, and David Langenau, PhD, co-organized this year's meeting. Read more

Advances in gene-editing therapies
In two gene-editing studies, one team makes the first CRISPR/CAS9 edits in human blood cells, another finds a way to make future transplant-based therapies safer and more efficient
Research updates